D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$773M |
| 2 |
Visa
V
|
+$674M |
| 3 |
HES
Hess
HES
|
+$541M |
| 4 |
Mastercard
MA
|
+$448M |
| 5 |
Oracle
ORCL
|
+$419M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.29B |
| 2 |
Advanced Micro Devices
AMD
|
+$979M |
| 3 |
Citigroup
C
|
+$477M |
| 4 |
Exxon Mobil
XOM
|
+$434M |
| 5 |
Booking.com
BKNG
|
+$355M |
Sector Composition
| 1 | Technology | 27.95% |
| 2 | Consumer Discretionary | 14.18% |
| 3 | Financials | 9.99% |
| 4 | Healthcare | 9.55% |
| 5 | Communication Services | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Ribbon Communications
RBBN
$676M
| $1.16M | ﹤0.01% |
362,064
-68,548
| -16% | -$219K |
|
1902
Royal Gold
RGLD
$12.5B
| $1.16M | ﹤0.01% |
9,506
+941
| +11% | +$115K |
|
1903
Utah Medical Products
UTMD
$200M
| $1.16M | ﹤0.01% |
16,251
+11,747
| +261% | +$835K |
|
|
DO
1904
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $1.15M | ﹤0.01% |
84,642
-157,419
| -65% | -$2.15M |
|
|
NVEI
1905
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $1.15M | ﹤0.01% |
36,500
-15,600
| -30% | -$493K |
|
|
EGRX
1906
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.15M | ﹤0.01% |
219,811
+56,321
| +34% | +$295K |
|
1907
Trinity Capital
TRIN
$1.13B
| $1.15M | ﹤0.01% |
78,416
+27,600
| +54% | +$405K |
|
1908
Rackspace Technology
RXT
$347M
| $1.15M | ﹤0.01% |
725,562
-415,614
| -36% | -$657K |
|
1909
CEMIG Preferred Shares
CIG
$5.84B
| $1.15M | ﹤0.01% |
+603,356
| New | +$1.15M |
|
|
CMRC
1910
Commerce.com, Inc. Series 1 Common Stock
CMRC
$370M
| $1.15M | ﹤0.01% |
166,220
-5,909
| -3% | -$40.7K |
|
1911
Grupo Cibest S.A. American Depositary Shares (each representing four (4) Preferred Shares)
CIB
$12.5B
| $1.14M | ﹤0.01% |
+33,298
| New | +$1.14M |
|
1912
AstraZeneca
AZN
$247B
| $1.13M | ﹤0.01% |
16,719
-1,551,062
| -99% | -$105M |
|
1913
Jefferies Financial Group
JEF
$13.7B
| $1.13M | ﹤0.01% |
25,673
-63,042
| -71% | -$2.78M |
|
|
CDMO
1914
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.13M | ﹤0.01% |
168,309
+12,001
| +8% | +$80.4K |
|
1915
Perdoceo Education
PRDO
$2.26B
| $1.13M | ﹤0.01% |
64,188
-58,711
| -48% | -$1.03M |
|
1916
First Trust Value Line Dividend Fund
FVD
$9.13B
| $1.12M | ﹤0.01% |
+26,613
| New | +$1.12M |
|
1917
Open Text
OTEX
$9.07B
| $1.12M | ﹤0.01% |
+28,784
| New | +$1.12M |
|
1918
Dolby
DLB
$6.85B
| $1.11M | ﹤0.01% |
13,302
-13,272
| -50% | -$1.11M |
|
1919
Afya
AFYA
$1.42B
| $1.11M | ﹤0.01% |
59,825
-24,792
| -29% | -$461K |
|
1920
Warner Bros
WBD
$46.7B
| $1.11M | ﹤0.01% |
127,137
-303,780
| -70% | -$2.65M |
|
1921
Zegna
ZGN
$2.22B
| $1.11M | ﹤0.01% |
+75,620
| New | +$1.11M |
|
|
ACCD
1922
DELISTED
Accolade, Inc. Common Stock
ACCD
| $1.11M | ﹤0.01% |
105,583
-218,851
| -67% | -$2.29M |
|
1923
J.M. Smucker
SJM
$11.5B
| $1.11M | ﹤0.01% |
8,780
-16,621
| -65% | -$2.09M |
|
1924
CRA International
CRAI
$1.3B
| $1.1M | ﹤0.01% |
7,384
+1,385
| +23% | +$207K |
|
1925
Columbus McKinnon
CMCO
$415M
| $1.1M | ﹤0.01% |
24,723
-7,996
| -24% | -$357K |
|